C-terminally truncated interferon
AssigneeLarge Scale Biology Corporation
InventorsStephen J. Reinl, Gregory P. Pogue
Life of this patent
Estimating the term…
Abstract
The invention described herein provides a C-terminally truncated interferon having enhanced biological activity and the polynucleotides encoding such interferon. Also provided are methods for producing and using such truncated interferon.
Claims14
An artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced biological activity.
A host cell comprising an expression vector wherein said vector comprises an artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced biological activity.
A process for producing a polypeptide comprising a C-terminally truncated interferon having enhanced biological activity comprising transforming a plant with an expression vector wherein said vector comprises an artificial polynucleotide encoding a poly peptide comprising a C-terminally truncated interferon.
A plant comprising an expression vector wherein said vector comprises an artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced biological activity.
Dependencies are inferred from the claim text.